Literature DB >> 28368522

Premature Ovarian Insufficiency: Phenotypic Characterization Within Different Etiologies.

Xue Jiao1,2,3,4, Huihui Zhang1,2,3,5, Hanni Ke1,2,3, Jiangtao Zhang1,2,3, Lei Cheng1,2,3, Yixun Liu6, Yingying Qin1,2,3, Zi-Jiang Chen1,2,3,7,8.   

Abstract

Context: Premature ovarian insufficiency (POI) is highly heterogeneous, both in phenotype and etiology. They are not yet clearly stated and correlated. Objective: To characterize clinical presentations of a large, well-phenotyped cohort of women with POI, and correlate phenotypes with etiologies to draw a comprehensive clinical picture of POI. Design, Patients, Interventions, and Main Outcome Measures: In this retrospective study, a total of 955 Chinese women with overt POI between 2006 and 2015 were systemically evaluated and analyzed. The phenotypic features, including menstrual characteristics, hormone profiles, ovarian ultrasonography/biopsy, pregnancy/family history, and genetic/autoimmune/iatrogenic etiologies were assessed and further compared within different subgroups.
Results: Among 955 women with POI, 85.97% presented with secondary amenorrhea (SA) and 14.03% with primary amenorrhea (PA). PA represented the most severe ovarian dysfunction and more chromosomal aberrations than SA. The decline of ovarian function in patients with SA progressed quickly. They had shortened reproductive periods (approximately 10 years) and developed amenorrhea within 1 to 2 years after menstrual irregularity. The ovaries were invisible or small, and the presence of follicles (28.43%) was correlated with other good reproductive indicators. Familial patients (12.25%) manifested better ovarian status and fewer chromosomal aberrations than sporadic patients. The etiologies consisted of genetic (13.15%), autoimmune (12.04%), and iatrogenic (7.29%), approximately 68% remaining idiopathic. There were significant differences among different etiologies, with the genetic group representing the most severe phenotype.
Conclusion: Our results regarding distinct phenotypic characteristics and association with different etiologies further confirmed the high heterogeneity of POI. Additional longitudinal clinical studies and pathogenesis research are warranted.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28368522     DOI: 10.1210/jc.2016-3960

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Current situation of menstruation and gynecological diseases prevalence among Chinese women: a cross-sectional study.

Authors:  Francis Manyori Bigambo; Dandan Wang; Yuqing Zhang; Sabitina Mrisho Mzava; Rongrong Dai; Xu Wang
Journal:  BMC Womens Health       Date:  2022-07-04       Impact factor: 2.742

2.  Genetic etiologic analysis in 74 Chinese Han women with idiopathic premature ovarian insufficiency by combined molecular genetic testing.

Authors:  Jiandong Shen; Dianyun Qu; Yan Gao; Fangxi Sun; Jiazi Xie; Xueping Sun; Daowu Wang; Xiang Ma; Yugui Cui; Jiayin Liu; Feiyang Diao
Journal:  J Assist Reprod Genet       Date:  2021-02-04       Impact factor: 3.412

3.  Engineering Functional Rat Ovarian Spheroids Using Granulosa and Theca Cells.

Authors:  Myung Jae Jeon; Young Sik Choi; Il Dong Kim; Tracy Criswell; Anthony Atala; James J Yoo; John D Jackson
Journal:  Reprod Sci       Date:  2021-01-28       Impact factor: 3.060

4.  Next Generation Sequencing Should Be Proposed to Every Woman With "Idiopathic" Primary Ovarian Insufficiency.

Authors:  Sarah Eskenazi; Anne Bachelot; Justine Hugon-Rodin; Genevieve Plu-Bureau; Anne Gompel; Sophie Catteau-Jonard; Denise Molina-Gomes; Didier Dewailly; Catherine Dodé; Sophie Christin-Maitre; Philippe Touraine
Journal:  J Endocr Soc       Date:  2021-03-01

Review 5.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

6.  MicroRNA-379-5p is associate with biochemical premature ovarian insufficiency through PARP1 and XRCC6.

Authors:  Yujie Dang; Xiaoyan Wang; Yajing Hao; Xinyue Zhang; Shidou Zhao; Jinlong Ma; Yingying Qin; Zi-Jiang Chen
Journal:  Cell Death Dis       Date:  2018-01-24       Impact factor: 8.469

Review 7.  Premature Ovarian Insufficiency: Past, Present, and Future.

Authors:  Seung Joo Chon; Zobia Umair; Mee-Sup Yoon
Journal:  Front Cell Dev Biol       Date:  2021-05-10

8.  Novel inactivating follicle-stimulating hormone receptor mutations in a patient with premature ovarian insufficiency identified by next-generation sequencing gene panel analysis.

Authors:  Asma Sassi; Julie Désir; Véronique Janssens; Martina Marangoni; Dorien Daneels; Alexander Gheldof; Maryse Bonduelle; Sonia Van Dooren; Sabine Costagliola; Anne Delbaere
Journal:  F S Rep       Date:  2020-08-22

9.  Primary Ovarian Insufficiency in Women With Addison's Disease.

Authors:  Elinor C Vogt; Lars Breivik; Ellen C Røyrvik; Marianne Grytaas; Eystein S Husebye; Marianne Øksnes
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

10.  Treg deficiency-mediated TH 1 response causes human premature ovarian insufficiency through apoptosis and steroidogenesis dysfunction of granulosa cells.

Authors:  Xue Jiao; Xiruo Zhang; Nianyu Li; Dunfang Zhang; Shidou Zhao; Yujie Dang; Peter Zanvit; Wenwen Jin; Zi-Jiang Chen; Wanjun Chen; Yingying Qin
Journal:  Clin Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.